MARKET

ICCC

ICCC

Immucell
NASDAQ
4.790
-0.220
-4.39%
After Hours: 5.02 +0.23 +4.80% 19:02 03/31 EDT
OPEN
4.964
PREV CLOSE
5.01
HIGH
5.15
LOW
4.790
VOLUME
9.86K
TURNOVER
--
52 WEEK HIGH
5.82
52 WEEK LOW
3.340
MARKET CAP
42.69M
P/E (TTM)
-18.1371
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ICCC last week (0324-0328)?
Weekly Report · 14h ago
IMMUCELL CORPORATION FORM 10-K
Press release · 3d ago
Weekly Report: what happened at ICCC last week (0317-0321)?
Weekly Report · 03/24 11:10
Weekly Report: what happened at ICCC last week (0310-0314)?
Weekly Report · 03/17 11:20
Weekly Report: what happened at ICCC last week (0303-0307)?
Weekly Report · 03/10 11:22
Weekly Report: what happened at ICCC last week (0224-0228)?
Weekly Report · 03/03 11:21
ImmuCell Posts Y/Y Q4 Earnings Growth, Awaits FDA Approval for Re-Tain
Barchart · 02/28 13:00
ImmuCell’s Earnings Call Highlights Robust Recovery
TipRanks · 02/28 00:57
More
About ICCC
More
ImmuCell Corporation is an animal health company. The Company is engaged in the development, acquisition, manufacture, and sale of products that improve the health and productivity of dairy and beef cattle. It operates in two business segments: Scours and Mastitis. The Scours segment is engaged in manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows. The First Defense product line provides bovine antibodies that newborn calves need but are unable to produce on their own immediately after birth. Its product line extension, Tri-Shield First Defense, is the first calf-level, passive antibody product providing Immediate Immunity against each of the three causes of calf scours (E. coli, coronavirus, and rotavirus).
Recently
Symbol
Price
%Change

Webull offers ImmuCell Corp stock information, including NASDAQ: ICCC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ICCC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ICCC stock methods without spending real money on the virtual paper trading platform.